NMRA Neumora Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
00:52
Jan 07
Jan 07
Long NMRA on VTYX acquisition spillover
Author argues NMRA will rally if VTYX is acquired, listing NMRA alongside GLUE and BIOA as beneficiaries. NMRA is described as the cheapest and most early-stage name among them.
MED
About NMRA Investor Commentary
Across the available history and selected sources, Buzzberg tracks NMRA (Neumora Therapeutics, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/IJesusChrist.